Advertisement

Advertisement

AU:CYC Stock Latest News

Technegas Secures Preferred Status in Landmark U.S. Lung Imaging Guidelines

Company AnnouncementsTechnegas Secures Preferred Status in Landmark U.S. Lung Imaging Guidelines

Cyclopharm Flags Uncertainties Around Financial Projections in ausbiz Briefing

PremiumCompany Announcements

Cyclopharm Flags Uncertainties Around Financial Projections in ausbiz Briefing

17d ago

Cyclopharm Adjusts Capital Structure as Conditional Share Rights Lapse

PremiumCompany Announcements

Cyclopharm Adjusts Capital Structure as Conditional Share Rights Lapse

1M ago

Cyclopharm Posts Record Half-Year Revenue but Defers U.S. Technegas Installation Target

PremiumCompany Announcements

Cyclopharm Posts Record Half-Year Revenue but Defers U.S. Technegas Installation Target

1M ago

Cyclopharm Director Kevin Barrow Steps Down but Retains Indirect Shareholding

PremiumCompany Announcements

Cyclopharm Director Kevin Barrow Steps Down but Retains Indirect Shareholding

3M ago

Cyclopharm Discloses Final Director Interest as Heaney Exits Board

PremiumCompany AnnouncementsCyclopharm Discloses Final Director Interest as Heaney Exits Board

3M ago

Cyclopharm shareholders back all resolutions at 2026 AGM

Company Announcements

Cyclopharm shareholders back all resolutions at 2026 AGM

3M ago

Cyclopharm Highlights Uncertainty and Liability Limits in 2026 AGM Presentation

Company Announcements

Cyclopharm Highlights Uncertainty and Liability Limits in 2026 AGM Presentation

3M ago

Cyclopharm Posts Record Revenue as U.S. Technegas Push Accelerates

PremiumCompany Announcements

Cyclopharm Posts Record Revenue as U.S. Technegas Push Accelerates

3M ago

Cyclopharm Touts Record Revenue as U.S. Technegas Rollout Accelerates

PremiumCompany Announcements

Cyclopharm Touts Record Revenue as U.S. Technegas Rollout Accelerates

3M ago

Cyclopharm Appoints New Director With No Current Security Holdings

PremiumCompany Announcements

Cyclopharm Appoints New Director With No Current Security Holdings

3M ago

Cyclopharm completes A$14m institutional share placement

PremiumCompany Announcements

Cyclopharm completes A$14m institutional share placement

4M ago

Cyclopharm seeks ASX quotation for over 5.2 million new shares

PremiumCompany AnnouncementsCyclopharm seeks ASX quotation for over 5.2 million new shares

4M ago

Cyclopharm names sole $5m investor in Tranche 2 placement

Company Announcements

Cyclopharm names sole $5m investor in Tranche 2 placement

4M ago

Cyclopharm sets 2026 AGM to vote on governance and capital measures

Company Announcements

Cyclopharm sets 2026 AGM to vote on governance and capital measures

4M ago

Cyclopharm Director John Wigglesworth Steps Down, Retains Shareholding

PremiumCompany Announcements

Cyclopharm Director John Wigglesworth Steps Down, Retains Shareholding

4M ago

Cyclopharm reshapes board as it accelerates Technegas push in U.S. market

PremiumCompany Announcements

Cyclopharm reshapes board as it accelerates Technegas push in U.S. market

4M ago

Cyclopharm lodges updated ASX corporate governance statement for 2025

PremiumCompany Announcements

Cyclopharm lodges updated ASX corporate governance statement for 2025

5M ago

Cyclopharm Showcases Global Reach and 2025 Performance in Annual Report

PremiumCompany Announcements

Cyclopharm Showcases Global Reach and 2025 Performance in Annual Report

5M ago

Cyclopharm Wins Multi-Site Technegas Deal with Northwestern Medicine

PremiumCompany AnnouncementsCyclopharm Wins Multi-Site Technegas Deal with Northwestern Medicine

5M ago

Cyclopharm Wins 11-Site Technegas Deal with University of Pennsylvania Health System

Company Announcements

Cyclopharm Wins 11-Site Technegas Deal with University of Pennsylvania Health System

5M ago

Cyclopharm Director Increases Indirect Shareholding via Share Purchase Plan

Company Announcements

Cyclopharm Director Increases Indirect Shareholding via Share Purchase Plan

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >